Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,040
Closed -$604K 1689
2025
Q1
$604K Buy
+15,040
New +$633K 0.01% 940
2024
Q3
Sell
-5,366
Closed -$227K 1527
2024
Q2
$227K Sell
5,366
-539
-9% -$23.6K 0.01% 1239
2024
Q1
$261K Sell
5,905
-261
-4% -$11.9K 0.01% 1097
2023
Q4
$284K Buy
6,166
+832
+16% +$35.4K 0.01% 1029
2023
Q3
$229K Buy
+5,334
New +$249K 0.01% 1043

Other funds holding QGEN

Vident Advisory's QGEN Position: Q2 2025 in Review

Vident Advisory sold out of Qiagen (QGEN) in Q2 2025, closing a stake of 15,040 shares — an estimated $604K sold.

Vident Advisory first reported a position in QGEN in Q3 2023 and held it in 5 quarters. The position peaked at $604K in Q1 2025. 317 funds tracked by Wall St. Rank hold QGEN as of Q2 2025.

  • Vident Advisory reported no remaining Qiagen position as of Q2 2025 after selling out during the quarter.
  • Vident Advisory sold 15,040 Qiagen shares in Q2 2025, an estimated $604K.
  • Vident Advisory first reported a position in Qiagen in Q3 2023 and held it in 5 quarters.
  • Vident Advisory's Qiagen position peaked at $604K in Q1 2025.
  • 317 funds tracked by Wall St. Rank held Qiagen as of Q2 2025.

Based on Vident Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.